Harvey E. Behrend

Array ( [id] => 4305844 [patent_doc_number] => 06326402 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Methods for treating viral infections using a compound capable of inhibiting microtubules' [patent_app_type] => 1 [patent_app_number] => 9/133071 [patent_app_country] => US [patent_app_date] => 1998-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11781 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326402.pdf [firstpage_image] =>[orig_patent_app_number] => 133071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158370 [patent_doc_number] => 06156780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Treatment of fecal incontinence' [patent_app_type] => 1 [patent_app_number] => 9/132041 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3867 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156780.pdf [firstpage_image] =>[orig_patent_app_number] => 132041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1384920 [patent_doc_number] => 06552060 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Asymmetric disulfides and methods of using same' [patent_app_type] => B1 [patent_app_number] => 09/132421 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 16 [patent_no_of_words] => 13029 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552060.pdf [firstpage_image] =>[orig_patent_app_number] => 09132421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383295 [patent_doc_number] => 06294559 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Antiproliferative agents associated with peroxisome proliferator activated receptors gamma1 and gamma2' [patent_app_type] => 1 [patent_app_number] => 9/128142 [patent_app_country] => US [patent_app_date] => 1998-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5296 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294559.pdf [firstpage_image] =>[orig_patent_app_number] => 128142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1543233 [patent_doc_number] => 06372772 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Inhibitors of redox signaling and methods of using same' [patent_app_type] => B1 [patent_app_number] => 09/127219 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11899 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372772.pdf [firstpage_image] =>[orig_patent_app_number] => 09127219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237622 [patent_doc_number] => 06143752 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Method for preventing or arresting liver damage in humans' [patent_app_type] => 1 [patent_app_number] => 9/126967 [patent_app_country] => US [patent_app_date] => 1998-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4981 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143752.pdf [firstpage_image] =>[orig_patent_app_number] => 126967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134490 [patent_doc_number] => 06121313 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Pharmaceutical composition in a form of self-emulsifying formulation for lipophilic compounds' [patent_app_type] => 1 [patent_app_number] => 9/123069 [patent_app_country] => US [patent_app_date] => 1998-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4960 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121313.pdf [firstpage_image] =>[orig_patent_app_number] => 123069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602807 [patent_doc_number] => 06432986 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches' [patent_app_type] => B1 [patent_app_number] => 09/118615 [patent_app_country] => US [patent_app_date] => 1998-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 29932 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432986.pdf [firstpage_image] =>[orig_patent_app_number] => 09118615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4288797 [patent_doc_number] => 06268388 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Method for preventing or treating erectile dysfunction by administering an endothelin antagonist' [patent_app_type] => 1 [patent_app_number] => 9/114355 [patent_app_country] => US [patent_app_date] => 1998-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1635 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268388.pdf [firstpage_image] =>[orig_patent_app_number] => 114355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384057 [patent_doc_number] => 06277891 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Nitric oxide inhibits rhinovirus infection' [patent_app_type] => 1 [patent_app_number] => 9/113310 [patent_app_country] => US [patent_app_date] => 1998-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 38 [patent_no_of_words] => 10339 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277891.pdf [firstpage_image] =>[orig_patent_app_number] => 113310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190541 [patent_doc_number] => 06153621 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Combined antagonist compositions' [patent_app_type] => 1 [patent_app_number] => 9/102089 [patent_app_country] => US [patent_app_date] => 1998-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 34 [patent_no_of_words] => 5869 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153621.pdf [firstpage_image] =>[orig_patent_app_number] => 102089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1520054 [patent_doc_number] => 06413519 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Use of an extract of the plant Terminalia catappa in the cosmetic and pharmaceutical fields, especially the dermatological field' [patent_app_type] => B1 [patent_app_number] => 09/102617 [patent_app_country] => US [patent_app_date] => 1998-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4104 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413519.pdf [firstpage_image] =>[orig_patent_app_number] => 09102617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421169 [patent_doc_number] => 06177469 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'Lipid alcohols as new immunosuppressive and antiviral drugs' [patent_app_type] => 1 [patent_app_number] => 9/051088 [patent_app_country] => US [patent_app_date] => 1998-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5485 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 332 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177469.pdf [firstpage_image] =>[orig_patent_app_number] => 051088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3987758 [patent_doc_number] => 05985331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Methods of use of phthalocyanines to inactivate blood borne parasites' [patent_app_type] => 1 [patent_app_number] => 8/952593 [patent_app_country] => US [patent_app_date] => 1998-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 6178 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985331.pdf [firstpage_image] =>[orig_patent_app_number] => 952593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410783 [patent_doc_number] => 06228890 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Use of alicyclic diamines as immunomodulators' [patent_app_type] => 1 [patent_app_number] => 9/011145 [patent_app_country] => US [patent_app_date] => 1998-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 3844 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228890.pdf [firstpage_image] =>[orig_patent_app_number] => 011145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4127530 [patent_doc_number] => 06127384 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Compounds, compositions and methods for treatment of hepatitis C' [patent_app_type] => 1 [patent_app_number] => 9/084538 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3063 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127384.pdf [firstpage_image] =>[orig_patent_app_number] => 084538 [rel_patent_id] =>[rel_patent_doc_number] =>)